Are Black patients with high-risk NSTE ACS less likely to receive evidence-based treatments compared to White patients?
Black and White patients with high-risk non-ST-elevation acute coronary syndromes (NSTE ACS)
Black race (observational disparity analysis)
White race
Receipt of evidence-based treatments
There are significant racial disparities in the management of high-risk NSTE ACS, with Black patients being less likely to receive newer or costly evidence-based treatments.
Black patients with NSTE ACS were less likely than whites to receive many evidence-based treatments, particularly those that are costly or newer. Longitudinal studies are needed to assess the long-term impact of these treatment disparities on clinical outcomes.
Building similarity graph...
Analyzing shared references across papers
Loading...
Ali F. Sonel
Chester B. Good
Jyotsna Mulgund
Circulation
University of North Carolina at Chapel Hill
University of Cincinnati
Wayne State University
Building similarity graph...
Analyzing shared references across papers
Loading...
Sonel et al. (Tue,) studied this question.
www.synapsesocial.com/papers/69d56fe675589c71d767daf6 — DOI: https://doi.org/10.1161/01.cir.0000157732.03358.64